For patients with a confirmed disc herniation, annular tear, or chronic discogenic pain, fibrin disc treatment may offer a minimally invasive alternative to microdiscectomy — particularly when nerve compression is not severe and the annular wall remains largely intact. Candidacy is evaluated individually, and outcomes vary by case, diagnosis, and overall spine health.

Two Paths After a Disc Diagnosis

When diagnostic imaging confirms a damaged disc — herniation, bulge, or annular tear — the conversation with a spine specialist typically turns to two broad categories of intervention: surgical decompression via microdiscectomy, or biologic disc repair using intra-annular fibrin injection. Understanding the mechanism, goals, and limitations of each approach helps patients and their care teams make well-informed decisions.

Understanding Microdiscectomy

Microdiscectomy is a surgical procedure designed to relieve nerve compression caused by a herniated disc. Through a small incision and under microscopic guidance, the surgeon removes the portion of disc material pressing on a nerve root. The primary objective is decompression — alleviating radiating leg pain (sciatica), numbness, tingling, or limb weakness caused by nerve impingement.

When Microdiscectomy Is Appropriate

For patients experiencing severe, progressive neurological deficits — such as rapid muscle weakness or loss of bladder or bowel control (cauda equina syndrome) — surgical decompression is often the most appropriate first-line intervention. When conservative care has failed over several weeks and nerve-compression symptoms are disabling, microdiscectomy can provide meaningful relief for many patients, with recovery often faster than traditional open discectomy.

Limitations and Long-Term Considerations

Microdiscectomy addresses nerve impingement by removing disc material — but it does not repair the annular tear that allowed the herniation to occur. This structural gap leaves the disc vulnerable. Reherniation at the same level is a recognized complication, and many patients continue to experience discogenic pain because the underlying annular defect remains unaddressed.

Additional risks associated with any surgical procedure include infection, bleeding, nerve injury, and scar tissue formation. Epidural fibrosis — scar tissue that forms around spinal nerves after surgery — can itself become a source of chronic pain. For patients whose primary complaint is chronic internal disc pain rather than acute nerve compression, microdiscectomy may relieve some symptoms while leaving the root structural problem untreated.

Expert Take

Our clinical team notes that many patients referred for evaluation after microdiscectomy still report chronic low back pain. In a number of these cases, the annular tear that initiated the herniation was never repaired. Addressing that tear — rather than only removing displaced disc material — can be a meaningful part of a longer-term disc management strategy for appropriate candidates.

Why Traditional Non-Surgical Approaches Sometimes Fall Short

Before considering either surgery or advanced biologic repair, most patients will have undergone a course of conservative care: physical therapy, anti-inflammatory medications, chiropractic treatment, and epidural steroid injections. These approaches serve an important role but have well-documented limitations for chronic disc pathology.

• Physical therapy strengthens supporting musculature and improves posture, but cannot seal an annular tear or stop the inflammatory cascade triggered by nucleus pulposus leaking through a torn annulus.
• Medications manage symptoms but do not promote structural disc healing.
• Epidural steroid injections may reduce nerve-related inflammation temporarily, but do not repair the disc itself, and repeated injections carry cumulative risks without addressing the underlying structural problem.

Patients who have exhausted conservative care yet are not appropriate surgical candidates — or who want to avoid the risks of surgery — may benefit from evaluation for biologic disc repair. For more detail on these treatment categories, see our overview of 5 non-surgical disc treatments for chronic back pain.

Fibrin Disc Treatment: A Biologic Approach to Disc Repair

Intra-annular fibrin injection — also referred to as biologic disc repair or fibrin disc treatment — takes a fundamentally different approach from surgical removal. Rather than excising disc material, the goal is to repair the disc from within by sealing the annular tear and supporting the body’s natural healing response.

How the Procedure Works

Under advanced imaging guidance (typically fluoroscopy and CT), a specialized fibrin sealant is precisely injected into the damaged disc, targeting the annular tear. Fibrin is a naturally occurring protein central to the body’s clotting and tissue-repair processes. When placed within the torn annulus, it acts as a biologic scaffold — reinforcing the structural wall, reducing leakage of inflammatory nuclear material, and creating a microenvironment that may support tissue regeneration.

The procedure is performed on an outpatient basis under local anesthesia and light sedation. There are no incisions, no removal of disc tissue, and no general anesthesia. Many patients return home the same day.

Conditions That May Respond to Fibrin Disc Treatment

Candidates evaluated for fibrin disc treatment often present with one or more of the following:

• Chronic discogenic low back pain — particularly pain originating from internal disc disruption or confirmed annular tears
• Degenerative disc disease — where disc breakdown contributes to pain and instability
• Contained disc herniations — where the outer annulus is compromised but nucleus pulposus has not fully extruded
• Persistent pain after prior spine surgery — including cases where an annular tear or discogenic component was not addressed by the original procedure

To understand more about how annular tears contribute to chronic pain, see our dedicated resource: Annular tears: a root cause of back pain and the role of annular tear repair.

Key Differences: Fibrin Disc Treatment vs. Microdiscectomy

1. Tissue Preservation vs. Tissue Removal

Microdiscectomy is an excisional procedure — it removes disc material to decompress a nerve. This can relieve radicular symptoms but alters the disc’s structural integrity and may accelerate degeneration at that segment over time. Intra-annular fibrin injection preserves the disc, adds structural support to the annular wall, and does not involve removal of any spinal tissue.

2. Addressing the Annular Tear

This is perhaps the most clinically significant distinction. Microdiscectomy does not repair the tear in the outer disc wall that allowed herniation to occur. That defect remains, leaving the disc susceptible to re-herniation and continued leakage of inflammatory chemicals. Fibrin disc treatment directly targets that tear — sealing it and reducing the ongoing inflammatory stimulus that drives discogenic pain in many patients.

3. Regenerative vs. Excisional Mechanism

By placing a biologic scaffold within the disc, fibrin disc treatment supports new tissue formation and annular strengthening. This regenerative mechanism contrasts with the excisional approach of microdiscectomy, which addresses the immediate symptom (nerve compression) without promoting structural disc recovery.

4. Recovery Profile and Risk Considerations

Because fibrin disc treatment is performed with a needle rather than a surgical incision, the recovery profile is generally less demanding. Many patients resume light activity within days and return to normal activities more quickly than following microdiscectomy. The risks associated with a needle-based outpatient procedure differ meaningfully from those of surgery — avoiding general anesthesia, operative blood loss, deep wound infection risk, and post-surgical scar tissue formation.

Outcomes vary by individual, and not every patient experiences the same recovery trajectory. Our clinical team evaluates each candidate carefully before recommending any treatment path.

5. A Potential Option After Failed Surgery

For patients who have already undergone microdiscectomy — or other spine surgeries — and continue to experience chronic pain, biologic disc repair may be worth evaluating. In some cases, persistent pain after surgery reflects an unresolved annular tear rather than inadequate decompression. Fibrin disc treatment has been studied in post-surgical populations, and outcomes in published research have been encouraging for appropriately selected patients, though individual results vary.

For more on this topic, see: After failed back surgery: is biologic disc repair your next step?

Choosing Between the Two: Key Decision Factors

The right approach depends on your specific diagnosis, symptom profile, and goals. As a general framework, our clinical team considers the following when evaluating candidates:

• Nature of the primary pain source: Acute nerve compression with progressive neurological deficits may favor prompt surgical evaluation. Chronic discogenic pain — particularly from annular tears — is a stronger indicator for biologic repair.
• Degree of disc containment: Contained herniations with an intact or partially intact annulus are often well-suited to intra-annular fibrin injection. Fully extruded or sequestered fragments may require a different approach.
• Prior treatment history: Patients who have tried and not benefited from conservative care — and who wish to avoid or defer surgery — are often appropriate candidates for fibrin disc treatment evaluation.
• Surgical urgency: Cauda equina syndrome and rapidly progressing motor deficits require urgent surgical consultation and are not candidates for elective biologic repair as a first step.

Expert Take

Our clinical team emphasizes that the choice between microdiscectomy and fibrin disc treatment is rarely black and white. Many patients fall into a diagnostic gray zone — they have nerve-related symptoms, but those symptoms arise primarily from ongoing annular disruption and disc inflammation rather than from a large, acutely compressed fragment. For these patients, repairing the disc rather than removing tissue from it may be a more durable path, though each case is evaluated on its own merits.

The Importance of a Thorough Evaluation

Neither treatment should be selected without a comprehensive workup. Appropriate evaluation includes advanced imaging (MRI is the standard; CT or discography may also be used), a detailed review of symptom history, and an assessment of what conservative measures have already been attempted. Understanding whether your pain is primarily nerve-compression-driven or disc-structural in origin is foundational to selecting the right intervention.

At Valor Spine, we conduct individualized evaluations to determine which patients are likely to benefit from biologic disc repair — and we are equally committed to referring patients to surgical specialists when that is the more appropriate path. To learn more about whether you may be a candidate, visit our resource: Am I a candidate for biologic disc repair? A detailed guide.

Additional Resources

For related reading, we recommend:

• Biologic disc repair vs. traditional spine surgery: what patients need to know
• 5 things to know about avoiding failed back surgery by trying regenerative disc repair first
• Annular tear repair: a non-surgical approach
• Degenerative disc disease: when conservative care stops working